Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis. D'Haens G, Dubinsky M, Kobayashi T, Irving PM, et al. N Engl J Med 2023;388:2444-2455.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

D'Haens G, Dubinsky M, Kobayashi T, Irving PM, et al. Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis. N Engl J Med 2023;388:2444-2455.
PMID: 37379135